A complete listing of currently available online programs is provided below. To view course materials click an available viewing format provided with each listing (PDF, HTML, Interactive). To access online exams and claim credit you must be registered and logged in. To add courses to your "MyAR Archives" user account select the "Add To Cart" button provided with each course title and follow the prompts.
* Advanced MRI Safety Training For Healthcare Professionals (4th Edition): Level 2 MR Personnel
|
Released:
April 22, 2020
•Expires:
March 31, 2024
|
CE credits:
3.0
• Cost:
$50.00
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|

This program reviews fundamental MRI safety information and meets the annual training recommendations from the American College of Radiology. Importantly, MRI facilities must now comply with the revised requirements for diagnostic imaging from The Joint Commission and document that MRI technologists participate in ongoing education that includes annual training on safe MRI practices in the MRI environment. Notably, Advanced MRI Safety Training for Healthcare Professionals, Level 2 MR Personnel covers each MRI safety topic specified by The Joint Commission, as well as many additional subjects that will expand the knowledge-base of healthcare professionals involved with MRI technology.
With 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present the information in this program.
Advanced MRI Safety Training for Healthcare Professionals (4th Edition), Level 2 MR Personnel is a 2 hour and 45 minute program that is divided into three different sections.
Educational Objectives
-
Understand the safety issues related to MRI.
-
Describe the bioeffects associated with the static magnetic field, time-varying magnetic fields, and radiofrequency fields.
-
Present guidelines that prevent projectile-related accidents.
-
Describe polices that avoid issues related to acoustic noise.
-
Review procedures that prevent burns associated with MRI.
-
Explain and demonstrate appropriate pre-MRI screening procedures.
-
Identify techniques to manage patients with claustrophobia, anxiety, or emotional distress.
-
Describe guidelines to handle medical emergencies in the MRI setting.
-
Understand the safety considerations for gadolinium-based contrast agents.
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
* Basic MRI Safety Training (4th Edition): Level 1 MR Personnel
|
Released:
May 03, 2023
•Expires:
May 31, 2026
|
CE credits:
1.0
• Cost:
$30.00
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|

Individuals entering the magnetic resonance imaging (MRI) environment, whether on a regular or infrequent basis, must be properly trained to ensure their safety, the protection of patients, and the security of other facility staff members. This program, Basic MRI Safety Training, Level 1 MR Personnel accomplishes the initial training that is necessary to ensure safety in the unique setting associated with the MRI system. It includes information pertaining to MRI technology, describes common hazards and unique dangers associated with the MRI setting, and presents vital recommendations and guidelines to prevent accidents and injuries. Importantly, this program provides the fundamental MRI safety information for Level I MR Personnel recommended by the American College of Radiology and may be utilized by individuals preparing for safety training as Level 2 MR Personnel.
With more than 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, www.MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present the information in this program.
Educational Objectives
-
Appreciate the importance of MRI
-
Identify the hazards associated with MRI
-
Understand the screening process
-
Describe steps to prevent accidents and injuries
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
* The Online Course for MR Safety Officers (MRSO) and MR Medical Directors (MRMD)
|
Released:
September 29, 2022
•Expires:
September 30, 2025
|
CE credits:
10.0
• Cost:
$750.00
|
Faculty:
William Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT | Kristan Harrington, MBA, R.T.(R)(MR), ARRT, MRSO
|

Applied Radiology and William Faulkner & Associates are pleased to introduce “The Online Course for MR Safety Officers (MRSO) and MR Medical Directors (MRMD)”. This comprehensive program, focusing on MR Safety, covers many aspects relating to the safety practices of the Magnetic Resonance Imaging (MRI) environment. It is designed for those individuals who are either currently serving as their facility’s MRSO and/or MRMD, or those who are preparing to assume these responsibilities. The content of this course will be helpful for those preparing for the American Board of Magnetic Resonance Safety MRSO and MRMD examinations.
The content of The Online Course for MR Safety Officers and MR Medical Directors is based upon current FDA and ACR guidelines, including the ACR Guidance Document for MR Safe Practices, as well as those promulgated by industry regulatory bodies such as the International Electrotechnical Commission.
The complete online program has been approved for up to 10 AMA PRA Category 1 credits™ (CME) and 10 Category A ARRT continuing educational credits (CE).
Module 1: Basic MRI Physics Relevant to MRI Safety
Module 2: Static Field: Bioeffects and Access Control
Module 3: Gradient Magnetic Fields: Bioeffects and Safety
Module 4: Radio Frequency Field: Bioeffects and Safety
Module 5: Implants and Devices
Module 6: Gadolinium-Based MR Contrast Agents
Module 7: MR Safety Screening
Module 8: Managing Emergent Situations and Patient Considerations: Quench and Patient Anxiety & Patient Monitoring
The Online Course for MR Safety Officers (MRSO) and MR Medical Directors (MRMD) is not affiliated with, nor endorsed by the American Board of Magnetic Resonance Safety (ABMRS)
Terms and Conditions of Use: Click To View
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
A Practical Approach to MR Imaging: Stability or High Relaxivity?
|
Released:
June 22, 2022
•Expires:
June 30, 2024
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Howard Rowley
|

In this CME/CE accredited program Dr. Howard Rowley reviews important efficacy considerations of the FDA approved gadolinium-based contrast agents (GBCAs), including clinical utility, safety issues, and practical approaches for selecting a GBCA when considering patient history, pathology and related risks.
Following Dr. Rowley's presentation, Dr. Rowley joins a panel of MR imaging experts in discussion about this important topic, followed by a moderated Q & A session with audience participation.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
List the key considerations in the choice of GBCAs, while balancing safety and efficacy.
-
Describe the transient effects of T1 and T2 relaxation during a GBCA bolus.
-
Understand the impact of high relaxivity gadolinium agents vs macrocyclic agents.
-
Design MRI protocols to optimize exam efficiency and enhanced lesion detection.
-
Implement GBCA protocols for special patient populations after considering risk assessment.
This program is made possible through an unrestricted educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Advanced CT Technology: Improving Workflow and Cost of Ownership
|
Released:
January 19, 2023
•Expires:
January 31, 2026
|
CE credits:
1.5
• Cost:
$0.00
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR | Rick Banner
|

CT Technology continues to evolve with modern platforms now being designed with improved patient comfort, increased workflow, and advanced applications supporting comprehensive diagnoses, precise treatment plans and better patient outcomes.
In this CE accredited Expert Forum Webinar, Rick Banner, RT (R), Senior Director of Marketing, Fujifilm Medical Systems U.S.A., Inc. shares insights into the design of advanced CT platforms that are addressing today’s clinical challenges while reducing the total cost of ownership. These advanced features will be supported by Dr. Lawrence N. Tanenbaum’s personal experience on how these advanced features are making a clinical difference in the day-to-day operations in busy imaging departments.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Implement advanced CT applications
-
Effectively manage obese and claustrophobic patients
-
Implement workflow considerations with improved CT service and reliability
Supported through an educational grant from FUJIFILM Medical Systems U.S.A., Inc.
|
|
|
|
Cardiovascular Imaging: Complex Applications in Cardiac CT and CT Angiography
|
Released:
June 08, 2021
•Expires:
July 31, 2026
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Richard Hallett, MD
|

Often there is lack of knowledge amongst imaging professionals regarding IV contrast dynamics and the relationship between contrast injection, observed enhancement, and scan acquisition timing. The design of appropriate imaging protocols leads to effective and consistent cardiovascular exams; especially when applied to complex clinical scenarios.
This CME/CE accredited program will review contrast-saline dynamics and discuss rational protocol design for cardiac and vascular CT angiography. Effective cardiovascular imaging protocols, utilizing multiple CT injector platforms to achieve optimal imaging, will be reviewed. We invite you to join Dr. Richard Hallett for a comprehensive discussion and case study review of this important topic.
Following the presentation questions from the audience were addressed in a moderated Q&A session.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Understand the relationship between bolus contrast media injection and observed enhancement.
-
Implement methods to design rational contrast injection / scan acquisition protocols.
-
Review various models of CT contrast injectors and discuss benefits, limitations, and injection protocol adjustments for each.
-
Apply customized contrast-saline injection / scan principles to complex cardiovascular disease cases.
Made possible through an unrestricted educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Clinical Applications & Imaging Considerations of Gadopiclenol Injection
|
Released:
May 10, 2023
•Expires:
May 31, 2026
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR
|

In September 2022, Gadopiclenol injection, which is both macrocyclic (stable) and has high relaxivity properties received FDA marketing approval and may provide dosing options that can decrease gadolinium exposure, particularly in vulnerable patients.
In this accredited Expert Forum webinar, the assessment of Gadopiclenol injection in neuro, body, and pediatric MR imaging will be presented by a panel of MR imaging experts and will include commentary from Lawrence N. Tanenbaum, MD. To encourage audience participation, a live Q & A session will follow the discussion.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the properties that distinguish Gadopiclenol injection from the other high-relaxivity and conventional gadolinium-based contrast agents.
-
Describe the clinical use of Gadopiclenol injection in neuro, body, and pediatric MRI applications.
-
Describe the clinical development program of Gadopiclenol injection for neuro and body MRI applications.
-
Apply clinical considerations and dosing options when selecting a macrocyclic, high relaxivity, MRI contrast in vulnerable patient populations.
This program has been sponsored by Guerbet LLC.
|
|
|
|
Clinical Utility of Barium Sulfate Products: Formulation Determines Appropriate Use
|
Released:
June 14, 2021
•Expires:
July 31, 2026
|
CE credits:
0.75
• Cost:
$0.00
|
Faculty:
Applied Radiology
|

Steven Sireci, MD
Barium-containing contrast media contain barium sulfate (BaSO4), as well as a number of additives. The BaSO4 provides radiodensity (ie, radio-opacity) and physical density (g/mL) to the suspension. Depending on the intended use of the contrast, the specific combination of additives provide other useful properties, including: BaSO4 particle suspension; mucosal coating; viscosity and texture; sweetness; filling and laxative effects; preservation; foaming prevention; and flavoring. Here we describe the purpose of each ingredient and additive found in BaSO4 contrast media products currently available for fluoroscopic and radiographic examinations. In addition, we review the role of these products in anatomic radiographic evaluation of the gastrointestinal (GI) tract and in evaluation of the physiology of swallowing. Finally, we review barium preparations used in computed tomography (CT) applications.
At the conclusion of this activity, participants will be able to:
-
Explain the role that BaSO4 plays in barium-containing contrast media;
-
Review the purpose of each ingredient/additive found in BaSO4 contrast media products available for fluoroscopic and radiographic examinations;
-
Describe the formulation of barium products that are appropriate for single- and double-contrast anatomic radiographic evaluation of the gastrointestinal (GI) tract;
-
Summarize qualities of the barium-containing contrast media used in evaluation of swallowing that make them most appropriate for that application; and,
-
State the properties of barium-containing contrast media used in computed tomography (CT) applications.
This program has been supported through an educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Clinical Utility of Barium Sulfate Products: Formulation Determines Appropriate Use
|
Released:
November 24, 2021
•Expires:
November 30, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Steven Sireci, MD
|

Depending on its intended application in Fluoroscopy or CT, Barium Sulfate (BaSO4) contains specific combinations of additional ingredients that support the diagnosis of disease, define treatment options, and improve patient outcomes. When used for the anatomical evaluation of the GI tract or the physiology of swallowing, a comprehensive understanding of the clinical utility of Barium products and their additives, is needed. This accredited program explains the differences and the benefits of each additive and is designed to increase knowledge about the clinical applications of Barium.
Dr. Sireci will provide a comprehensive overview of each Barium product, its indication and intended use. Following the presentation, the audience is invited to join Dr. Sireci for lively Q & A session.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the role that BaSO4 plays in barium-containing contrast media.
-
Review the purpose of each ingredient/additive found in BaSO4 contrast media products currently available for fluoroscopic and radiographic examinations.
-
Describe the formulation of barium products that are appropriate for single and double contrast anatomic radiographic evaluation of the gastrointestinal (GI) tract.
-
Summarize qualities of the barium-containing contrast media used in evaluation of swallowing that make them most appropriate for that application.
-
State the properties of barium-containing contrast media used in computed tomography (CT) applications
Educational Credits
One (1) AHRA CRA Credit
Made possible through an educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Contrast Media Basics: Important Considerations for the Pharmacist
|
Released:
February 07, 2022
•Expires:
February 29, 2024
|
CE credits:
2.5
• Cost:
$0.00
|
Faculty:
William Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT | Kristan Harrington, MBA, R.T.(R)(MR), ARRT, MRSO | Rutu Patel, PharmD, RPh
|
Applied Radiology has developed this two-part, on-demand webinar and accompanying digital monograph to increase overall understanding of the properties, clinical benefits, and safety considerations of iodinated and gadolinium-based contrast agents (GBCAs). The goal of this program is to fully prepare pharmacy personnel to make informed decisions regarding contrast media selection.
The complete online program has been approved for up to 2.5 ACPE and Category A ARRT continuing educational credits.
Part 1: Contrast Media Basics
Part 2: A Pharmacist’s Guide to Gadolinium-Based Contrast Agents
Part 3: Monograph
This program was supported through an educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Contrast-Enhanced MRI: Optimizing Imaging of the Brain and Spine
|
Released:
November 24, 2021
•Expires:
November 30, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR | Susie Bash, MD
|
In this Expert Forum, Lawrence Tanenbaum, MD, FACR and Suzie Bash, MD review considerations for optimizing contrast-enhanced MRI in neuroimaging, extending from patient tolerance to standardizing procedures. Following the presentation questions from the audience were addressed in a moderated Q&A session.
Educational Objectives:
-
Manage issues related to patient tolerability and acute adverse events.
-
Implement standardized and optimized MR contrast-enhanced protocols.
-
Identify clinical indications for contrast-enhanced MRI for brain and spine imaging
Supported by GE Healthcare
|
|
|
|
Development and Use of Eluciremâ„¢ (gadopiclenol) Injection, a Macrocyclic, High-relaxivity GBCA for CE-MRI
|
Released:
February 24, 2023
•Expires:
March 31, 2026
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Applied Radiology
|

After decades of administrations, substantial evidence has accumulated for the efficacy and safety of gadolinium-based contrast agents (GBCAs) in magnetic resonance imaging (MRI). However, their excellent performance has led to increased use and dosing for many neuro and cardiovascular applications in adults and children.
As a result, concern has been growing in the radiology community, particularly with respect to use of the less stable agents, which are generally linear and, therefore, bind less tightly to the gadolinium (Gd) ion. While recognizing the value of these agents, the US Food and Drug Administration (FDA) and the American College of Radiology (ACR) now recommend limiting patient Gd exposure where possible.
One technique for reducing Gd exposure is to use a high-relaxivity GBCA that can be used at a lower dose than a conventional GBCA without impact on image quality. Until recently, however, the GBCA with the highest relaxivity was a linear agent. Consequently, it has been widely recognized for some time that it would be preferable if a GBCA was both macrocyclic in structure and high relaxivity, and that such an agent could be used to reduce Gd exposure by decreasing the amount of Gd injected.
A new GBCA that is both macrocyclic and high relaxivity has been developed and received FDA marketing approval in September 2022. A group of radiologists with extensive experience in contrast-enhanced (CE)-MRI convened to discuss this new GBCA, Elucirem™ (gadopiclenol) injection, and this monograph presents a summary of this expert panel forum.
At the conclusion of this activity, participants will be able to:
-
Describe the properties that distinguish Elucirem from the other high-relaxivity and conventional GBCAs;
-
Demonstrate an understanding of the clinical development program of Elucirem for neuro and body imaging;
-
Define the patient populations that are most vulnerable to higher and/or repeat dosing of GBCAs; and,
-
Explain the factors to be considered when deciding to use MRI contrast in vulnerable patient populations.
This content is supported by Guerbet, LLC.
|
|
|
|
Diagnosis and Management of Swallowing Physiology: Standardized Contrast, the MBSImPâ„¢, & the IDDSI Framework
|
Released:
May 03, 2023
•Expires:
May 31, 2026
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Applied Radiology
|

Catriona M. Steele, PhD, Bonnie Martin-Harris, PhD, Memorie Gosa, PhD, Stephanie Edwards Allen, BSRT, MBA
The MBSS, also known as a video fluoroscopic swallow study (VFSS), is a barium-sulfate–enhanced fluoroscopic motion study used to evaluate anatomy and swallowing physiology simultaneously in real time. Varibar, an FDA-approved barium sulfate product for evaluation of dysphagia, together with The Modified Barium Swallow Impairment Profile (MBSImP), are used to ensure standardization and reproducibility in the MBSS. This monograph explains the relationship between Varibar, the MBSImP, and the International Dysphagia Diet Standardisation (IDDSI) framework in evaluation of swallowing in clinical practice.
At the conclusion of this activity, participants will be able to:
-
Explain how the modified barium swallow study (MBSS), The Modified Barium Swallow Impairment Profile (MBSImP), and barium sulfate products are used to evaluate dysphagia
-
Describe the development of FDA-approved barium sulfate products used to assess dysphagia
-
Review the International Dysphagia Diet Standardisation (IDDSI) framework: what it is and how it was developed
-
Define the relationship between the MBSS, the MBSImP, barium sulfate, and IDDSI, and how they are used in clinical practice
-
Summarize pediatric and clinical-practice considerations in performing the MBSS
This program has been supported through an educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Imaging Bulk Package: A Compliant Solution in the CT Suite
|
Released:
January 01, 2019
•Expires:
March 31, 2024
|
CE credits:
1
• Cost:
$0.00
|
Faculty:
Assorted Faculty
|

Since the 1990’s, multi-patient contrast administration has been available in the form of the Pharmacy Bulk Package (PBP), which is still offered by several contrast vendors. The FDA required that all related Prescribing Information (PI) sheets for the PBP include specific directions for the dispensing of the contrast from the PBP container. The PI language describes withdrawing the contrast from the bottle in a suitable work area, specifically “a laminar flow hood, using aseptic techniques”. However, this method is not possible in most CT Suites, as laminar flow hoods are generally located in the Pharmacy, not the CT suite.
Therefore, during the last decade, regulators have begun to have concerns about the use of PBP. In 2009, The Joint Commission began citing imaging providers who were using PBP to fill power injector syringes in what they considered an unsuitable work area, as described in the manufacturer’s PBP guidelines for the dispensing of contrast.
This Expert Forum will review the steps taken by the contrast media industry and the FDA to develop a safe and compliant solution for multi-patent contrast administration in CT. This solution is now available as the Imaging Bulk Package (IBP) which is approved for use in the CT Suite. This panel will also share their comprehensive process for incorporating IBP into their clinical practice.
Supported through an unrestricted educational grant from Bracco Diagnostics Inc.
|
|
|
|
Implementing a Contrast-Enhanced Mammography Program
|
Released:
December 15, 2021
•Expires:
November 30, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Matthew F. Covington, MD
|
In this Expert Forum, Dr. Matthew Covington shares his understanding of the benefits and limitations of contrast-enhanced mammography, as compared to contrast-enhanced breast MRI, and how this imaging technique can be incorporated into clinical practice. Following the presentation questions from the audience were addressed in a moderated Q&A session.
Learning Objectives
-
Dictate the strengths and limitations of contrast-enhanced mammography compared to contrast-enhanced breast MRI.
-
Recognize indications for the appropriate use of contrast-enhanced mammography.
-
Implement a contrast-enhanced mammography program.
This program is made possible through an unrestricted educational grant from FUJIFILM Healthcare Americas Corporation.
|
|
|
|
Liver MR Image Acquisition for Technologists Using a Hepatobiliary Agent
|
Released:
June 01, 2023
•Expires:
June 30, 2026
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Patricia Barnick, BSRT
|
This On-Demand version of this Expert Forum webinar, attendees heard about liver magnetic resonance image acquisition utilizing a hepatobiliary agent. You will learn more about Eovist (gadoxetate sodium) including details on its properties, applications in liver imaging and important safety information.
Through a case study review, details on how your liver imaging protocols and workflow can be optimized will be discussed
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Describe the key properties and application of Eovist.
-
Implement protocols to optimize workflow.
-
Characterize lesions associated with various liver disease through a review of case examples.
This program has been sponsored by Bayer Healthcare.
|
|
|
|
Managing Iodinated Contrast Shortages: ‘Real World’ Solutions
|
Released:
July 18, 2022
•Expires:
July 31, 2024
|
CE credits:
1.5
• Cost:
$0.00
|
Faculty:
Applied Radiology
|

Ryan Lee, MD, MBA • Daniel Karolyi, MD • Matthew Kuhn, MD, FACR • Mahmud Mossa-Basha, MD • Joseph Cavallo, MD, MBA
This CE accredited program will provide an educational resource that addresses current and future iodinated contrast media shortages and its clinical impact.
By bringing together a group of radiologists with expertise in CT, MRI, NM/PET, US & AI, who have experienced this crisis in their imaging departments and who have established ‘best practices and procedures’ designed to address clinical and operational alternatives in order to deliver safe and effective patient care throughout Radiology; this comprehensive program will cover the following topics:
-
The operational impact of contrast media waste.
-
The use of saline supporting contrast optimization with improved image quality.
-
Patient safety considerations & imaging challenges when moving to alternative imaging methods.
-
When and how to implement emergency protocols, based on iodinated contrast availability.
-
The use of AI to provide improved outcomes without the use of contrast.
Clinical scenarios that include IV and oral contrast administration, patient management, non-contrast imaging options, and the use of Barium and other contrast media will be discussed.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Identify which imaging exams may be affected by a shortage of iodinated contrast media.
-
Implement emergency protocols to continue providing safe and effective patient care.
-
Manage clinical challenges associated with moving from one preferred imaging modality to another (i.e., CT vs MRI vs NM vs US)
-
Employ the use of AI solutions to support imaging capabilities and address patient specific imaging outcomes.
This program is made possible through an educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Managing Patients with Passive Implants on Vertical Field MR Systems
|
Released:
August 10, 2022
•Expires:
August 31, 2025
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR | Frank G. Shellock, PhD, FACC, FACR, FACSM | William Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT
|

MRI technology has advanced with the availability of low - vertical field scanners. However, many patients present with passive implants and devices that are available in clinical practice, yet not approved for MR imaging in low field scanners.
In this CE/CME program three MR imaging experts will provide unique perspectives on managing patients with passive implants and devices. The panel will discuss important MRI safety information and details on how to safely image these patients, including a review of screening policies, implant and device manufacturers’ information and resources, and the implementation plan for a MRI safety program, designed to mitigate the potential risks to patients presenting with passive implants and devices.
Learning Objectives
-
Identify challenges associated with imaging patients with passive implants on low field (<1.5-T) MR systems.
-
Review MRI considerations in order to safely manage patients that present with passive implants referred for scans on low field MR systems.
-
Implement protocols to safely scan patients presenting with passive implants that are not labeled for low field scanners, including 1.2-T MR systems.
-
Increase the number of patients eligible for MRI exams.
This program is made possible through an unrestricted educational grant from FUJIFILM Healthcare Americas Corporation.
|
|
|
|
MR Contrast Agents: Safety Considerations and Clinical Practices
|
Released:
November 22, 2021
•Expires:
November 30, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR
|
In this Expert Forum, Dr. Lawrence Tanenbaum, MD, FACR, will review the classification of Gadolinium MR contrast agents according to their molecular structure, ionicity, and stability. The impact of these properties and supporting clinical data for safety considerations in choosing an agent will be discussed with the goal of providing insight that can be applied in everyday clinical practice. Following the presentation questions from the audience were addressed in a moderated Q&A session.
Educational Objectives:
-
To review the current landscape of Gadolinium-based contrast agents and their classification according to their molecular structure, ionicity, and stability.
-
To understand how these properties impact the safety and efficacy of GBCAs.
-
To review the important clinical data that impact safety considerations in choosing an MR contrast agent and how that applies to everyday clinical practice.
Supported by GE Healthcare
|
|
|
|
MR Contrast Selection & Utilization in Pediatric & Neonatal Patients
|
Released:
November 22, 2021
•Expires:
November 30, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Chetan C. Shah, MD, MBA
|

In MR Imaging, a careful review of the safety criteria for the selection of a Gadolinium-based Contrast Agents (GBCAs) should be considered for pediatric and neonatal patients. The program will provide a comprehensive review of the supporting research that addresses Gadolinium selection in this special patient population. Both chronic and long-term effects of GBCAs will be discussed.
As a Pediatric Neuroradiologist, Dr. Shah is uniquely qualified to share his experience which includes a discussion of risk vs benefits, supported by practical protocols for the administration of MR contrast; including limiting the amount of contrast given to patients that may receive several lifetime doses. Following the presentation, the audience is invited to join Dr. Shah for an interactive Q & A session.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Explain the differences between available MR contrast agents and any associated adverse events
-
Improve clinical management decisions about when to administer MR contrast (risk vs benefit)
-
Apply FDA guidelines regarding MRI contrast agents to clinical practice.
Made possible through an unrestricted educational grant from Bracco Diagnostics, Inc.
|
|
|
|
MRI Contrast Selection: Greater Stability or Higher Relaxivity?
|
Released:
June 22, 2022
•Expires:
June 30, 2024
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Applied Radiology
|

Howard Rowley, MD, FACR; Lorna P. Browne, MD; Kevin J. Chang, MD, FACR; Christopher Comstock, MD, FACR; J. Paul Finn, MD; Scott Reeder, MD, PhD; Max Wintermark, MD
Currently, 6 general-use gadolinium-based contrast agents (GBCA) are available and approved for a variety of MRI indications, including brain, body, and breast imaging, in adults and children. Gadolinium-based contrast agents comprise a gadolinium (Gd) ion bound to an organic ligand to form a chelate. Whether the chelate is linear or macrocyclic and ionic or nonionic impacts the size and stability of the Gd-chelate complex, as well as its distribution and elimination. In addition, the chelate structure also impacts the relaxivity, or r value, of the GBCA, which dictates the ability to provide contrast enhancement relative to background. Understanding the different safety and efficacy profiles of GBCAs can be valuable when selecting a GBCA. Here, we present discussions from a recent Expert Panel Forum focused on the safety and efficacy of GBCAs, as well as specific considerations related to their selection for neuroimaging, pediatric imaging, body imaging, and breast imaging applications.
At the conclusion of this activity, participants will be able to:
-
Describe the distinguishing properties of the available gadolinium-based contrast agents (GBCAs) currently used for magnetic resonance imaging (MRI);
-
Review how the structure of the gadolinium (Gd)-chelate complex determines the stability of a GBCA, and how stability relates to both Gd retention and nephrogenic systemic fibrosis (NSF);
-
Explain what a “high-relaxivity” GBCA is and summarize results of crossover studies comparing standard- and high-relaxivity GBCAs for MRI; and,
-
State the key considerations when selecting a GBCA for neuro MRI, pediatric MRI, body MRI, and breast MRI.
This program was supported through an educational grant from Bracco Diagnostics, Inc..
|
|
|
|
MRI Safety Considerations for Implants and Devices
|
Released:
February 01, 2023
•Expires:
February 28, 2026
|
CE credits:
1.5
• Cost:
$30.00
|
Faculty:
Frank G. Shellock, PhD, FACC, FACR, FACSM
|

This accredited program provides a comprehensive overview of MRI safety considerations for passive / active implants, and devices.
When considering patient safety during MR imaging, it is critical to assess the patient’s history and have a clear understanding of any passive and or active implants and/or devices. The ACR Manual on MR Safety states that the Radiologist is responsible for the safety of the patient undergoing the MRI Exam. They are also responsible for implementing MR Safety policies and procedures and ensuring that the facilities’ personnel adhere to them at all time. Regarding implants and devices, regular reviews and updates to the MRI safety policy should be completed.
With more than 35 years of experience in the field of MRI, the author of the best-selling textbook series, the Reference Manual for Magnetic Resonance Safety, Implants and Devices, and the creator of the internationally popular website, www.MRIsafety.com, Dr. Frank G. Shellock is uniquely qualified to present this important MRI Safety information designed for MRI Imaging professionals.
Educational Objectives
-
Name and describe the current labeling terminology for implants & devices.
-
Safely image patients with passive and active, MR Conditional implants and devices.
-
Establish a comprehensive MRI Safety protocol for imaging implants & devices.
Program support provided by Bracco Diagnostics, Inc.
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
MRI Safety Considerations For The Radiologist
|
Released:
February 16, 2023
•Expires:
February 28, 2026
|
CE credits:
1.5
• Cost:
$30.00
|
Faculty:
William Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT | Kristan Harrington, MBA, R.T.(R)(MR), ARRT, MRSO
|

This accredited program provides a comprehensive overview of MRI safety including the radiologist's responsibilities and liabilities, MRI staff education and patient safety. It is designed specifically for practicing radiologists, fellows, residents, and healthcare professionals who oversee MRI services and will provide practical guidance from two respected MRI safety educators who present information on accepted safety standards of care based on the 2020 ACR Manual on MR Safety, the 2021 FDA Guidance Document, and a review of the literature.
Program Considerations: It is critical to have established MRI safety protocols and to have a clear understanding of the basics of MRI Safety. The ACR Manual on MR Safety states that the Radiologist is responsible for the safety of the patient undergoing the MRI Exam. They are also responsible for implementing MR Safety policies and procedures and ensuring that the facilities’ personnel adhere to them at all time. These MRI safety policies should be reviewed and updated annually in order to prevent patient injury.
Educational Objectives
-
Describe the difference between Level 1 & Level 2 MR personnel.
-
Differentiate and identify the ACR-designated Safety Zones.
-
Implement safety considerations for the static magnetic field, time-varying gradient magnetic fields, and radiofrequency fields.
-
Employ procedures and protocols to prevent RF-related burns and methods to manage SAR levels.
-
Manage acute and chronic gadolinium-based contrast agent adverse events.
Program support provided by Bracco Diagnostics, Inc.
This is a Pay-To-View program. Purchase is required for full program access.
|
|
|
|
New Advances in CT Technology for Coronary Plaque Assessment
|
Released:
June 01, 2023
•Expires:
June 30, 2026
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Dinesh Kalra, MD, FACC, FSCCT, FSCMR, FNLA
|

This CME and CE accredited program aims to provide a comprehensive overview of new artificial intelligence applications supporting cardiac CT. Through clinical case study reviews, Dr. Dinesh Kalra will share his clinical knowledge and insights into cardiovascular imaging and provide examples of super-resolution, deep-learning reconstructive technologies that are improving cardiac CT image quality and the overall diagnostic confidence in cardiovascular case interpretations.
Dr. Kalra stated, “I'm able to better see the same segments that were difficult to see with older generation scanners. The image sharpness, the resolution, and the low-contrast detection rates have all improved and there's no trade-off, so one doesn’t sacrifice resolution for radiation dose. This allows us to deliver less radiation, see less noise, while obtaining superb image quality.” Following the presentation questions from the audience were addressed in a moderated Q&A session.
Educational Objectives:
At the completion of this activity, participants should be able to:
-
Describe the various reconstruction techniques and their clinical utility in coronary CT.
-
Incorporate advanced AI processing solutions that achieve higher resolutions into cardiac CT imaging protocols in order to improve clinical outcomes.
-
Increase diagnostic confidence in the interpretation of stenosis and plaque characterization.
This program has been sponsored by Canon Medical Systems, USA
|
|
|
|
Synthetic 2D Mammography: The Roadmap for Interpreting Digital Breast Tomosynthesis
|
Released:
December 15, 2021
•Expires:
December 01, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Laurie L. Fajardo, MD
|
Dr. Laurie Fajardo will share her understanding of the benefits of synthetic 2D images with digital breast tomosynthesis (DBT) for diagnosing breast cancer along with considerations for implementing Synthetic 2D breast imaging protocols into your practice. Following the presentation questions from the audience were addressed in a moderated Q&A session.
Learning Objectives
-
Implement digital breast tomosynthesis protocols in clinical practice.
-
Differentiate characteristics of synthetic 2D mammography by manufacturer.
-
Discuss differences between wide vs narrow angle DBT acquisition and its effect of angular range on synthetic-2D image generation.
This program is made possible through an unrestricted educational grant from FUJIFILM Healthcare Americas Corporation.
|
|
|
|
The Modified Barium Swallow Study: When, How, and Why?
|
Released:
September 17, 2021
•Expires:
September 30, 2023
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Applied Radiology
|

Margaret M. Fynes, MD; Christine Smith, MS; and Martin B. Brodsky, PhD, ScM
Dysphagia is a common clinical challenge, particularly in the elderly. The modified barium swallow study (MBSS), initially developed by radiologists and speech-language pathologists (SLPs) at The Johns Hopkins Hospital, is critically important for evaluation and treatment of dysphagia. In this article, the authors, radiologist Margaret M. Fynes, MD, and two SLPs, Christine Smith, MS, and Martin B. Brodsky, PhD, ScM, review the technical and patient considerations for optimal performance of the MBSS according to The Johns Hopkins protocol. Because both perspectives, radiologist and SLP, are included, the article is able to highlight the importance of the role of each, as well as how they work together. Elements of the MBSS that have become more standardized over time, specifically the barium sulfate contrast agent products used, and the scoring and reporting of the examination with the Modified Barium Swallowing Impairment Profile (MBSImP), are described, and the contribution of this standardization to the overall accuracy and reliability of the MBSS is discussed.
At the conclusion of this activity, participants will be able to:
-
Review the causes and incidence of dysphagia
-
Describe technical and patient considerations associated with performing a fluoroscopic modified barium swallow study (MBSS) to evaluate dysphagia
-
Explain how the MBSS contributes to the evaluation and treatment of patients with dysphagia by assessing the cause of dysphagia and allowing implementation of compensatory strategies in real-time
-
Explain the importance of the relationship between the radiologist and speech-language pathologist (SLP) during performance of the MBSS >
-
Explain how use of a standardized series of barium sulfate contrast agent products, as well as use of the Modified Barium Swallowing Impairment Profile (MBSImP), have contributed to standardization of the MBSS examination
-
Detail the benefits of MBSS standardization on the robustness and consistency of the examination
This Program Has Been Supported Through An Unrestricted Educational Grant from Bracco Diagnostics, Inc.
|
|
|
|
The Proper Use of Saline During Contrast Injection
|
Released:
October 13, 2022
•Expires:
October 31, 2025
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Richard Hallett, MD | Rutu Patel, PharmD, RPh | Stephanie Allen, MBA, RT(R)(MR), CJCP
|
This 3-part on-demand program is designed to increase the participant's understanding about the oversight, management, and dispensing of saline for medical imaging. Specifically developed for pharmacists, it is intended to increase pharmacy personnel’s knowledge about the clinical benefits of saline utilization during imaging; intended to improve patient care. Radiologic technologists and others healthcare professionals that support imaging, may find this accredited program of interest.
The complete online program has been approved for up to 1.25 ACPE and Category A ARRT and CRA continuing educational credits.
Part 1: The Pharmacists Roles and Responsibilities
Part 2: The Clinical Benefits Of Saline Injection During CT Angiography
Part 3: Digital Monograph | The Proper Use of Saline: Overview and Resources
This program was supported through an educational grant from Bracco Diagnostics, Inc.
|
|
|
|
Use of Contrast-Enhanced MRI in 'At Risk' Patient Populations
|
Released:
July 28, 2022
•Expires:
August 31, 2024
|
CE credits:
1.0
• Cost:
$0.00
|
Faculty:
Lawrence N. Tanenbuam, MD, FACR | Donna Roberts, MD
|

Gadolinium-based contrast agents (GBCAs) differ in structure and ionicity which, in turn affects their stability and safety profiles. The more stableagents are associated with a lower risk of nephrogenic systemic fibrosis (NSF) and less Gd deposition in brain, bone, and other tissues. Several patient populations are considered vulnerable to Gd exposure, including children, the elderly, the renally impaired, and those that require repeat MRI exams.
In these cases, GBCA utilization should be limited to studies where the results contribute significantly to the diagnosis and/or patient management.
In the following webinar and corresponding monograph, Lawrence N. Tanenbaum, MD, FACR and Donna Roberts, MD share case examples including MRI applications and considerations for understanding at risk adult and pediatric patient populations when performing Neuro MRI.
Educational Objectives:
-
Identify patient populations at increased risk of experiencing an adverse event following administration of a GBCA.
-
Understand and discuss risk factors related to the use of GBCA's in specific patient populations.
-
Implement alternative approaches for the clinical management of at risk patients.
Supported through an educational grant from GE Healthcare
|
|
|
|